Citation Impact
Citing Papers
MRI detection of single particles for cellular imaging
2004
High field MRI in the diagnosis of multiple sclerosis: high field–high yield?
2009
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis
1996
Molecular imaging and therapy of atherosclerosis with targeted nanoparticles
2007
Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage
2001
MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”
2006
Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures
2006
Sjögren's syndrome
2005 Standout
Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond
2011
USPIO-enhanced MR imaging of macrophage infiltration in native and transplanted kidneys: initial results in humans
2007
Treatment of Intracranial Aneurysms Using the Pipeline Flow-Diverter Embolization Device: A Single-Center Experience with Long-Term Follow-Up Results
2012
Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging
2007 Standout
From Threat to Fear: The Neural Organization of Defensive Fear Systems in Humans
2009 StandoutNobel
High angular resolution diffusion imaging reveals intravoxel white matter fiber heterogeneity
2002 Standout
Detection of Synovial Macrophages in an Experimental Rabbit Model of Antigen-induced Arthritis: Ultrasmall Superparamagnetic Iron Oxide–enhanced MR Imaging
2004
In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging
2007
Imaging in the era of molecular oncology
2008 StandoutNature
Imaging of multiple sclerosis: Role in neurotherapeutics
2005
Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro
2006
Imaging, Distribution, and Toxicity of Superparamagnetic Iron Oxide Magnetic Resonance Nanoparticles in the Rat Brain and Intracerebral Tumor
2005
Guillain-Barré syndrome
2016 Standout
Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent
2006
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Magnetic nanoparticles for theragnostics
2009
Amyotrophic lateral sclerosis
2011 Standout
Multiple Sclerosis: Low-Frequency Temporal Blood Oxygen Level–Dependent Fluctuations Indicate Reduced Functional Connectivity—Initial Results
2002
MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process
2015
A 3‐year magnetic resonance imaging study of cortical lesions in relapse‐onset multiple sclerosis
2009
Advanced MRI and staging of multiple sclerosis lesions
2016
The contributions of myelin and axonal caliber to transverse relaxation time in shiverer and neurofilament-deficient mouse models
2010
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis
1998
The pathology of primary progressive multiple sclerosis
2004
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
2006
Nanoplatforms for Targeted Molecular Imaging in Living Subjects
2007
Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging
2008
Dysmyelination Revealed through MRI as Increased Radial (but Unchanged Axial) Diffusion of Water
2002 Standout
Periventricular Heterotopia: An X-Linked Dominant Epilepsy Locus Causing Aberrant Cerebral Cortical Development
1996
Nanowire Sensors for Medicine and The Life Sciences
2006
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Iron oxide MR contrast agents for molecular and cellular imaging
2004 Standout
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
2004
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial
2009
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging
2001
Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron
2008
Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T
2003
Clearance of Iron Oxide Particles in Rat Liver
2006
Recent advances in iron oxide nanocrystal technology for medical imaging☆
2006
Chlorinative stress: An under appreciated mediator of neurodegeneration?
2006
A Nanoparticle Size Series for In Vivo Fluorescence Imaging
2010 StandoutNobel
Multiple Sclerosis
2000 Standout
Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles
2009
Graphene-based semiconductor photocatalysts
2011 Standout
Future applications of DWI in MS
2001
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy
1996
Specific E-selectin targeting with a superparamagnetic MRI contrast agent
2006
The role of magnetic resonance techniques in understanding and managing multiple sclerosis
1998
Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application
2007 Standout
Magnetic Resonance Imaging of Angiographically Occult Runoff Vessels in Peripheral Arterial Occlusive Disease
1992
Macrophage-induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors
2008
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis
1999
Imaging macrophages with nanoparticles
2014
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
1996 StandoutNature
Spinal cord MRI in multiple sclerosis—diagnostic, prognostic and clinical value
2015
Multiple sclerosis
2002 Standout
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
2006 Standout
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.
2000
Imaging Inflammation in Acute Brain Ischemia
2007
Concepts of myelin and myelination in neuroradiology.
2000
Toxic Potential of Materials at the Nanolevel
2006 StandoutScience
Incorporation of Iron Oxide Nanoparticles and Quantum Dots into Silica Microspheres
2008 StandoutNobel
Functional Nucleic Acid Sensors
2009 Standout
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1998 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
MRI of Macrophages in Infectious Knee Synovitis
2010
Superparamagnetic Iron Oxide Nanoparticles in Biomedicine: Applications and Developments in Diagnostics and Therapy
2013
Self-Assembled Monolayers of Thiolates on Metals as a Form of Nanotechnology
2005 Standout
Cellular MR Imaging
2005
Luminescent Chemodosimeters for Bioimaging
2012 Standout
MRI Detection of Thrombin with Aptamer Functionalized Superparamagnetic Iron Oxide Nanoparticles
2008
Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis
1999
Imaging, Distribution, and Toxicity of Superparamagnetic Iron Oxide Magnetic Resonance Nanoparticles in the Rat Brain and Intracerebral Tumor
2005
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Multiple Sclerosis
2018 Standout
Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system
2005
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
2002
Inorganic nanoparticles in porous coordination polymers
2016 StandoutNobel
Monodisperse MFe2O4 (M = Fe, Co, Mn) Nanoparticles
2003 Standout
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Graphene-Like Two-Dimensional Materials
2013 Standout
Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions.
2007
Endovascular Treatment of Intracranial Aneurysms With Flow Diverters
2013 Standout
Imaging Characteristics of Zinc Sulfide Shell, Cadmium Telluride Core Quantum Dots
2008
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal
2009
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles
2003
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies
2003
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Diagnostic criteria for primary progressive multiple sclerosis: A position paper
2000
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents.
2007
Cortical lesions in primary progressive multiple sclerosis
2009
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Self-Assembled Virus-like Particles with Magnetic Cores
2007 StandoutNobel
Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging.
2000
Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy
2015
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS
2001
Magnetic nanoparticles as markers for cellular MR imaging
2004
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
2015
Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review
2009
Characteristics of Ultrasmall Superparamagnetic Iron Oxides in Patients with Brain Tumors
2005
Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
2009
In vivo imaging of spinal cord atrophy in neuroinflammatory diseases
2014
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
The prevalence of Sjogren syndrome in patients with primary progressive multiple sclerosis
2001
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
2018
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages
2006
Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine Tumors
2009
Works of Vincent Dousset being referenced
Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE
2006
A multicenter measurement of magnetization transfer ratio in normal white matter
1999
Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance Imaging
2004
Adapted focal experimental autoimmune encephalomyelitis to allow MRI exploration of multiple sclerosis features
2011
Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 T
2008
Incidence of Asymptomatic Intracranial Embolic Events After Pulmonary Vein Isolation
2011
Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: Consensus report of the white matter study group
2005
Magnetic Resonance Imaging of Human Brain Macrophage Infiltration
2007
Flow-Diverter Silk Stent for the Treatment of Intracranial Aneurysms: 1-year Follow-Up in a Multicenter Study
2012
Correlation between Clinical Status and Macrophage Activity Imaging in the Central Nervous System of Rats
2002
MRI in multiple sclerosis: current status and future prospects
2008
Diffusion tensor MRI of the spinal cord
2000
In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance
1999
MS Lesions Are Better Detected with 3D T1 Gradient-Echo Than with 2D T1 Spin-Echo Gadolinium-Enhanced Imaging at 3T
2014
In vivovisualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging
2009
Assessment of Disease Activity in Multiple Sclerosis Phenotypes with Combined Gadolinium- and Superparamagnetic Iron Oxide–enhanced MR Imaging
2012
Popliteal artery hemodynamics: MR imaging-US correlation.
1991
Predicting progression in primary progressive multiple sclerosis: A 10‐year multicenter study
2008
Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis
1994
Dose and scanning delay using USPIO for central nervous system macrophage imaging
1999
A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis
1995
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging.
1992
Primary and transitional progressive MS
1999
MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium.
2006
Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
1997
Two-year follow-up study of primary and transitional progressive multiple sclerosis
2002
Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer.
1995
Dose and scanning delay using USPIO for central nervous system macrophage imaging
1999
Early structural changes in acute MS lesions assessed by serial magnetization transfer studies
1998
Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis.
1999
Long-term clinical outcome of primary progressive MS: Predictive value of clinical and MRI data
2005
Macrophage brain infiltration in experimental autoimmune encephalomyelitis is not completely compromised by suppressed T-cell invasion: in vivo magnetic resonance imaging illustration in effective anti-VLA-4 antibody treatment
2004
MR Imaging in White Matter Diseases of the Brain and Spinal Cord
2005